These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27819314)

  • 1. Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin.
    Hu BL; Shi C; Lei RE; Lu DH; Luo W; Qin SY; Zhou Y; Jiang HX
    Sci Rep; 2016 Nov; 6():36436. PubMed ID: 27819314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.
    Sun X; He Y; Ma TT; Huang C; Zhang L; Li J
    Mol Cell Biochem; 2014 Mar; 388(1-2):11-23. PubMed ID: 24242045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.
    Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J
    Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.
    He Y; Huang C; Sun X; Long XR; Lv XW; Li J
    Cell Signal; 2012 Oct; 24(10):1923-30. PubMed ID: 22735812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
    Yu F; Fan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
    Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
    Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
    Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
    Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.
    Xiang DM; Sun W; Ning BF; Zhou TF; Li XF; Zhong W; Cheng Z; Xia MY; Wang X; Deng X; Wang W; Li HY; Cui XL; Li SC; Wu B; Xie WF; Wang HY; Ding J
    Gut; 2018 Sep; 67(9):1704-1715. PubMed ID: 28754776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
    Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
    Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
    Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
    DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.